Live feed08:30:00·13dPRReleasevia QuantisnowAlpha Tau Receives FDA Clearance to Complete Enrollment in REGAIN Recurrent Glioblastoma Trial and Add Two U.S. Clinical Sites; Early Interim Results Showed 100% Local Disease ControlByQuantisnow·Wall Street's wire, on your screen.DRTS· Alpha Tau Medical Ltd.Health Care
